Moizah Saad, DO
Internal Medicine · Trenton, NJNPI 1336400431
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 30.5% of the total. That places this record below the midpoint for internal medicine clinicians in NJ, where the typical reported total is $332.
Across 8 payments — averaging $21.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$53
- Boehringer Ingelheim$26
- Medtronic$25
- Gilead$24
- Alkermes, Inc.$22
- E.r. Squibb & Sons, L.L.C.$22
What the payments were for
- Food & beverage$172100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Boehringer Ingelheim | 1 | $26 |
| Medtronic | 1 | $25 |
| Gilead | 1 | $24 |
| Alkermes, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
How this compares
$172 in reported general payments places this provider in the 35th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $29,941 |
| JanuviaSitagliptin Phosphate | 17 | $14,565 |
| Atorvastatin Calcium | 71 | $882 |
| Levothyroxine Sodium | 46 | $733 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $579 |
| Losartan Potassium | 40 | $513 |
| Metoprolol Succinate | 32 | $430 |
| Tamsulosin Hcl | 16 | $396 |
| Rosuvastatin Calcium | 27 | $382 |
| Gabapentin | 23 | $363 |
| Omeprazole | 13 | $315 |
| Pantoprazole Sodium | 16 | $258 |
| Simvastatin | 32 | $221 |
| Metformin Hcl | 21 | $214 |
| Amlodipine Besylate | 46 | $199 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Trenton
- Edward LaubTrenton$39K
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.